Matches in Wikidata for { <http://www.wikidata.org/entity/Q92020629> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q92020629 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92020629 description "scientific article published on 17 April 2020" @default.
- Q92020629 description "wetenschappelijk artikel" @default.
- Q92020629 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q92020629 name "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 name "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 type Item @default.
- Q92020629 label "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 label "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 prefLabel "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 prefLabel "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 P1433 Q92020629-39363454-0DFF-43E3-9D69-0574073AD2ED @default.
- Q92020629 P1476 Q92020629-DA9269DF-D099-4DE4-A1A7-2050E36E6EC1 @default.
- Q92020629 P2093 Q92020629-1ABD2771-C903-41BB-8C8B-64C4C2DD865A @default.
- Q92020629 P2093 Q92020629-3556A1DD-0C0F-4200-9AAF-AC703C8D6466 @default.
- Q92020629 P2093 Q92020629-372A30F1-6394-443E-9CDC-35287BAFEBBE @default.
- Q92020629 P2093 Q92020629-9DAC4B4A-2280-4C37-9688-26DC023CC76A @default.
- Q92020629 P2093 Q92020629-B5B7C795-B819-478C-A709-A627EBA49257 @default.
- Q92020629 P2093 Q92020629-C67EECA4-034F-4395-921D-36094ED6F8EA @default.
- Q92020629 P2093 Q92020629-C94E01E0-64C9-44EA-B657-18B5A1F1CCB9 @default.
- Q92020629 P2093 Q92020629-DD06D891-535F-412F-9474-D4B6BEE81B08 @default.
- Q92020629 P31 Q92020629-FBCA50A9-3C59-4BA8-B3B4-55A909ACD5DA @default.
- Q92020629 P356 Q92020629-9D8059CC-4C2F-4A03-BA09-73A62C200AB0 @default.
- Q92020629 P50 Q92020629-0F7C4A27-A312-4362-90D4-58F7829A4218 @default.
- Q92020629 P50 Q92020629-2E5219A6-01E3-43D8-A185-AF120161508F @default.
- Q92020629 P50 Q92020629-9A24C202-D474-46FA-9A3A-4BB713ACC72A @default.
- Q92020629 P577 Q92020629-2F3ACB89-0A5A-4CEF-B36C-49E47915859A @default.
- Q92020629 P698 Q92020629-F614969F-E5C4-4ECA-8C17-F6054544A6D5 @default.
- Q92020629 P921 Q92020629-747C9E42-5EA1-4ACC-AFCC-BF773FE6D560 @default.
- Q92020629 P921 Q92020629-DF5A1AD5-134F-4D9E-8D6A-177BA0469100 @default.
- Q92020629 P356 AB8A8A @default.
- Q92020629 P698 32303014 @default.
- Q92020629 P1433 Q972896 @default.
- Q92020629 P1476 "Dual Targeted Therapy in HER2-positive Breast Cancer Cells with the Combination of Carbon Dots/HER3 siRNA and Trastuzumab" @default.
- Q92020629 P2093 "Chulang Yu" @default.
- Q92020629 P2093 "Feng Gao" @default.
- Q92020629 P2093 "Guili He" @default.
- Q92020629 P2093 "Mengjun Shu" @default.
- Q92020629 P2093 "Min Zeng" @default.
- Q92020629 P2093 "Xu Lin" @default.
- Q92020629 P2093 "Yan Wu" @default.
- Q92020629 P2093 "Zhihua Zhou" @default.
- Q92020629 P31 Q13442814 @default.
- Q92020629 P356 "10.1088/1361-6528/AB8A8A" @default.
- Q92020629 P50 Q82270916 @default.
- Q92020629 P50 Q89086504 @default.
- Q92020629 P50 Q98568057 @default.
- Q92020629 P577 "2020-04-17T00:00:00Z" @default.
- Q92020629 P698 "32303014" @default.
- Q92020629 P921 Q125754601 @default.
- Q92020629 P921 Q412616 @default.